Agape ATP Corporation (NASDAQ:ATPC) Short Interest Update

Agape ATP Corporation (NASDAQ:ATPC) saw a significant growth in short interest in the month of July. As of July 31st, there was short interest totaling 29,079 shares, a growth of 88.6% from the July 15th total of 15,420 shares. Currently, 3.0% of the shares of the stock are short sold. Based on an average trading volume of 3,579,723 shares, the short-interest ratio is currently 0.0 days.

Institutional Trading of Agape ATP

An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC grew its holdings in Agape ATP Corporation (NASDAQ:ATPC) by 95.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 65,130 shares of the company’s stock after purchasing an additional 31,849 shares during the quarter. Citadel Advisors LLC owned about 0.13% of Agape ATP worth $82,000 as of its most recent SEC filing. Institutional investors own 0.01% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently issued reports on ATPC shares. Wall Street Zen upgraded shares of Agape ATP from a “sell” rating to a “hold” rating in a research report on Monday, June 29th. Weiss Ratings restated a “sell (e+)” rating on shares of Agape ATP in a research report on Friday, May 22nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

Agape ATP Stock Performance

Shares of ATPC traded up $0.09 during trading hours on Monday, hitting $2.58. 212,507 shares of the stock were exchanged, compared to its average volume of 2,530,933. The stock’s 50-day moving average price is $2.82 and its two-hundred day moving average price is $2.80. Agape ATP has a 12-month low of $1.72 and a 12-month high of $73.50. The company has a market cap of $2.58 million, a price-to-earnings ratio of -1.94 and a beta of 0.38.

Agape ATP (NASDAQ:ATPC) last announced its quarterly earnings data on Friday, August 14th. The company reported $0.15 earnings per share for the quarter. Agape ATP had a negative return on equity of 5.38% and a negative net margin of 106.90%.The company had revenue of $0.01 million for the quarter.

About Agape ATP

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.